SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: dowman who wrote (9401)6/1/1998 11:26:00 PM
From: Grainne  Respond to of 14328
 
Dowman, it is too depressing over here to hang out, so I just drop by occasionally. Because of that, I miss some posts once in awhile.

I assume OTC is their new PR firm? Is it a disreputable one?



To: dowman who wrote (9401)6/1/1998 11:48:00 PM
From: DMore  Read Replies (2) | Respond to of 14328
 
You must remember TRIBY is building a company first and while
concerned about stock price, do not make it a top priority,
as if the company is built correctly then the stock will
follow. Management will not waste alot of money on PR now.
When the time is right, and the fundamentals there, more $$
will be allocated to PR. Stocks moving just on hype or no
fundamentals don't last long and management usually dumps
their stock in the run. While I do agree more could be done
here, patience will be rewarded. I have been involved since
the IPO. I don't think anyone else can top that.
It is very hard for small and emerging companies to find good
quality PR. It just doesn't exist. Having talked to many
small companies, I know this to be true.
If TRIBY keeps growing and income increasing, the bigger firms
will come and that is better than PR.
D